Skip to main content
Clinical Trials/NCT00065624
NCT00065624CompletedPhase 2

Antioxidant Functions of Lipoic Acid

National Center for Complementary and Integrative Health (NCCIH)1 site in 1 country16 target enrollmentStarted: November 1, 2003Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
16
Locations
1

Study Overview

Brief Summary

The goal of this study is to determine whether a short treatment with lipoic acid, an antioxidant used in the treatment of diabetic neuropathy, improves blood vessel reactivity and decreases oxidant stress in persons with elevated blood cholesterol.

Detailed Description

As per Brief Summary

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double

Eligibility Criteria

Ages
50 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Lipid criteria for inclusion are a plasma LDL between 160 and 190 mg/dl (total cholesterol usually 240-285 mg/dl)
  • •Less than 2 coronary risk factors, and already on a cholesterol-lowering diet.

Exclusion Criteria

  • •Overt or clinical atherosclerosis
  • •Currently taking cholesterol-lowering medication.
  • •Subjects with other lipid disorders
  • •Subjects taking supplemental lipoic acid, vitamin C, or vitamin E.

Investigators

Study Sites (1)

Loading locations...

Similar Trials